AngioDynamics宣布,公司在2026财年第四季度及全年取得了创纪录的财务表现。这一业绩得益于其战略的持续有效执行,成功推动了医疗技术业务的增长,并实现了全年的整体盈利。
AngioDynamics宣布,公司在2026财年第四季度及全年取得了创纪录的财务表现。这一业绩得益于其战略的持续有效执行,成功推动了医疗技术业务的增长,并实现了全年的整体盈利。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.